3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
10
Liver Neoplasms
2
Thyroid Nodule
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Hyperthyroidism
1
Hypertension, Portal
1
Colorectal Neoplasms
1
Interventions
napabucasin
2
linifanib
1
Vaccines
1
Sorafenib
1
Radiofrequency Ablation
1
Papillomavirus Vaccines
1
Leucovorin
1
Irinotecan
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Gemcitabine
1
Fluorouracil
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms, Glandular and Epithelial
×
Radiofrequency Ablation
×
Clear all
NCT02192671
2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3
Unknown
120 enrolled